يعرض 1 - 7 نتائج من 7 نتيجة بحث عن '"MESH: Idarubicin"', وقت الاستعلام: 1.16s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Non-lethal Right Liver Atrophy After TIPS Occlusion in A Cirrhotic Patient: Introducing The Hepatic Biembolization ; Comparison of two transarterial chemoembolization strategies for hepatocellular carcinoma.

    المؤلفون: Le Roy, Bertrand, Gagniere, Johan, Pezet, Denis, Buc, Emmanuel, Tavernier, Jerome, Fagnoni, Philippe, Chabrot, Pascal, Guiu, Boris, Vadot, Lucie, Aho, Serge, Boyer, Louis, Abergel, Armand, Hillon, Patrick, Sautou, Valérie, Boulin, Mathieu

    المساهمون: CHU Estaing Clermont-Ferrand, CHU Clermont-Ferrand, Service Chirurgie Disgestive, CHU Clermont-Ferrand-CHU Clermont-Ferrand, Microbes, Intestin, Inflammation et Susceptibilité de l'Hôte (M2iSH), Institut National de la Recherche Agronomique (INRA)-Université d'Auvergne - Clermont-Ferrand I (UdA), Pharmacie CHU de Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Institut Pascal (IP), SIGMA Clermont (SIGMA Clermont)-Université Clermont Auvergne 2017-2020 (UCA 2017-2020 )-Centre National de la Recherche Scientifique (CNRS), Service de radiologie et d'Imagerie médicale diagnostique et thérapeutique (CHU de Dijon), Service d'épidémiologie et d'hygiène hospitalières (CHU de Dijon), Image Science for Interventional Techniques (ISIT), Université d'Auvergne - Clermont-Ferrand I (UdA)-Clermont Université-Centre National de la Recherche Scientifique (CNRS), Université Bourgogne Franche-Comté COMUE (UBFC), Institut de Chimie de Clermont-Ferrand (ICCF), SIGMA Clermont (SIGMA Clermont)-Institut de Chimie - CNRS Chimie (INC-CNRS)-Université Clermont Auvergne 2017-2020 (UCA 2017-2020 )-Centre National de la Recherche Scientifique (CNRS)

    المصدر: ISSN: 0250-7005 ; Anticancer Research ; https://hal.science/hal-02095434Test ; Anticancer Research, 2014, 34 (12), pp.7247-53. ⟨10.1007/s11605-016-3133-z⟩.

    مصطلحات موضوعية: Transarterial chemoembolization, efficacy, hepatocellular carcinoma, strategy, tolerance, MESH: Aged, MESH: Antibiotics, Antineoplastic, MESH: Liver Neoplasms, MESH: Male, MESH: Retrospective Studies, MESH: Treatment Outcome, MESH: Carcinoma, Hepatocellular, MESH: Chemoembolization, Therapeutic, MESH: Epirubicin, MESH: Ethiodized Oil, MESH: Female, MESH: Humans, MESH: Idarubicin, MESH: Infusions, Intra-Arterial, [SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing, [SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25503156; hal-02095434; https://hal.science/hal-02095434Test; PUBMED: 25503156

    الإتاحة: https://doi.org/10.1007/s11605-016-3133-zTest
    https://hal.science/hal-02095434Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Non-lethal Right Liver Atrophy After TIPS Occlusion in A Cirrhotic Patient: Introducing The Hepatic Biembolization ; Comparison of two transarterial chemoembolization strategies for hepatocellular carcinoma.

    المؤلفون: Le Roy, Bertrand, Gagniere, Johan, Pezet, Denis, Buc, Emmanuel, Tavernier, Jerome, Fagnoni, Philippe, Chabrot, Pascal, Guiu, Boris, Vadot, Lucie, Aho, Serge, Boyer, Louis, Abergel, Armand, Hillon, Patrick, Sautou, Valérie, Boulin, Mathieu

    المساهمون: CHU Estaing Clermont-Ferrand, CHU Clermont-Ferrand, Service Chirurgie Disgestive, CHU Clermont-Ferrand-CHU Clermont-Ferrand, Microbes, Intestin, Inflammation et Susceptibilité de l'Hôte (M2iSH), Institut National de la Recherche Agronomique (INRA)-Université d'Auvergne - Clermont-Ferrand I (UdA), Pharmacie CHU de Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Institut Pascal (IP), SIGMA Clermont (SIGMA Clermont)-Université Clermont Auvergne 2017-2020 (UCA 2017-2020 )-Centre National de la Recherche Scientifique (CNRS), Service de radiologie et d'Imagerie médicale diagnostique et thérapeutique (CHU de Dijon), Service d'épidémiologie et d'hygiène hospitalières (CHU de Dijon), Image Science for Interventional Techniques (ISIT), Université d'Auvergne - Clermont-Ferrand I (UdA)-Clermont Université-Centre National de la Recherche Scientifique (CNRS), Université Bourgogne Franche-Comté COMUE (UBFC), Institut de Chimie de Clermont-Ferrand (ICCF), SIGMA Clermont (SIGMA Clermont)-Institut de Chimie - CNRS Chimie (INC-CNRS)-Université Clermont Auvergne 2017-2020 (UCA 2017-2020 )-Centre National de la Recherche Scientifique (CNRS)

    المصدر: ISSN: 0250-7005 ; Anticancer Research ; https://hal.science/hal-02095434Test ; Anticancer Research, 2014, 34 (12), pp.7247-53. ⟨10.1007/s11605-016-3133-z⟩.

    مصطلحات موضوعية: Transarterial chemoembolization, efficacy, hepatocellular carcinoma, strategy, tolerance, MESH: Aged, MESH: Antibiotics, Antineoplastic, MESH: Liver Neoplasms, MESH: Male, MESH: Retrospective Studies, MESH: Treatment Outcome, MESH: Carcinoma, Hepatocellular, MESH: Chemoembolization, Therapeutic, MESH: Epirubicin, MESH: Ethiodized Oil, MESH: Female, MESH: Humans, MESH: Idarubicin, MESH: Infusions, Intra-Arterial, [SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing, [SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25503156; hal-02095434; https://hal.science/hal-02095434Test; PUBMED: 25503156

    الإتاحة: https://doi.org/10.1007/s11605-016-3133-zTest
    https://hal.science/hal-02095434Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Comparison of two transarterial chemoembolization strategies for hepatocellular carcinoma.

    المؤلفون: Tavernier, Jerome, Fagnoni, Philippe, Chabrot, Pascal, Guiu, Boris, Vadot, Lucie, Aho, Serge, Boyer, Louis, Abergel, Armand, Hillon, Patrick, Sautou, Valérie, Boulin, Mathieu

    المساهمون: CHU Clermont-Ferrand, Pharmacie CHU de Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Institut Pascal (IP), SIGMA Clermont (SIGMA Clermont)-Université Clermont Auvergne 2017-2020 (UCA 2017-2020 )-Centre National de la Recherche Scientifique (CNRS), Image Science for Interventional Techniques (ISIT), Université d'Auvergne - Clermont-Ferrand I (UdA)-Clermont Université-Centre National de la Recherche Scientifique (CNRS), Service de radiologie et d'Imagerie médicale diagnostique et thérapeutique (CHU de Dijon), Service d'épidémiologie et d'hygiène hospitalières (CHU de Dijon), Université Blaise Pascal - Clermont-Ferrand 2 (UBP)-SIGMA Clermont (SIGMA Clermont)-Centre National de la Recherche Scientifique (CNRS), Université Bourgogne Franche-Comté COMUE (UBFC)

    المصدر: ISSN: 0250-7005 ; Anticancer Research ; https://hal.science/hal-02095438Test ; Anticancer Research, 2014, 34 (12), pp.7247-53.

    مصطلحات موضوعية: Transarterial chemoembolization, efficacy, hepatocellular carcinoma, strategy, tolerance, MESH: Aged, MESH: Antibiotics, Antineoplastic, MESH: Female, MESH: Humans, MESH: Idarubicin, MESH: Infusions, Intra-Arterial, MESH: Liver Neoplasms, MESH: Male, MESH: Retrospective Studies, MESH: Treatment Outcome, MESH: Carcinoma, Hepatocellular, MESH: Chemoembolization, Therapeutic, MESH: Epirubicin, MESH: Ethiodized Oil, [SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing, [SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25503156; hal-02095438; https://hal.science/hal-02095438Test; PUBMED: 25503156

    الإتاحة: https://hal.science/hal-02095438Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Non-lethal Right Liver Atrophy After TIPS Occlusion in A Cirrhotic Patient: Introducing The Hepatic Biembolization ; Comparison of two transarterial chemoembolization strategies for hepatocellular carcinoma.

    المؤلفون: Le Roy, Bertrand, Gagniere, Johan, Pezet, Denis, Buc, Emmanuel, Tavernier, Jerome, Fagnoni, Philippe, Chabrot, Pascal, Guiu, Boris, Vadot, Lucie, Aho, Serge, Boyer, Louis, Abergel, Armand, Hillon, Patrick, Sautou, Valérie, Boulin, Mathieu

    المساهمون: CHU Estaing Clermont-Ferrand, CHU Clermont-Ferrand, Service Chirurgie Disgestive, CHU Clermont-Ferrand-CHU Clermont-Ferrand, Microbes, Intestin, Inflammation et Susceptibilité de l'Hôte (M2iSH), Institut National de la Recherche Agronomique (INRA)-Université d'Auvergne - Clermont-Ferrand I (UdA), Pharmacie CHU de Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Institut Pascal (IP), SIGMA Clermont (SIGMA Clermont)-Université Clermont Auvergne 2017-2020 (UCA 2017-2020 )-Centre National de la Recherche Scientifique (CNRS), Service de radiologie et d'Imagerie médicale diagnostique et thérapeutique (CHU de Dijon), Service d'épidémiologie et d'hygiène hospitalières (CHU de Dijon), Image Science for Interventional Techniques (ISIT), Université d'Auvergne - Clermont-Ferrand I (UdA)-Clermont Université-Centre National de la Recherche Scientifique (CNRS), Université Bourgogne Franche-Comté COMUE (UBFC), Institut de Chimie de Clermont-Ferrand (ICCF), SIGMA Clermont (SIGMA Clermont)-Institut de Chimie - CNRS Chimie (INC-CNRS)-Université Clermont Auvergne 2017-2020 (UCA 2017-2020 )-Centre National de la Recherche Scientifique (CNRS)

    المصدر: ISSN: 0250-7005 ; Anticancer Research ; https://hal.science/hal-02095434Test ; Anticancer Research, 2014, 34 (12), pp.7247-53. ⟨10.1007/s11605-016-3133-z⟩.

    مصطلحات موضوعية: Transarterial chemoembolization, efficacy, hepatocellular carcinoma, strategy, tolerance, MESH: Aged, MESH: Antibiotics, Antineoplastic, MESH: Liver Neoplasms, MESH: Male, MESH: Retrospective Studies, MESH: Treatment Outcome, MESH: Carcinoma, Hepatocellular, MESH: Chemoembolization, Therapeutic, MESH: Epirubicin, MESH: Ethiodized Oil, MESH: Female, MESH: Humans, MESH: Idarubicin, MESH: Infusions, Intra-Arterial, [SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing, [SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25503156; hal-02095434; https://hal.science/hal-02095434Test; PUBMED: 25503156

    الإتاحة: https://doi.org/10.1007/s11605-016-3133-zTest
    https://hal.science/hal-02095434Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Comparison of two transarterial chemoembolization strategies for hepatocellular carcinoma.

    المؤلفون: Tavernier, Jerome, Fagnoni, Philippe, Chabrot, Pascal, Guiu, Boris, Vadot, Lucie, Aho, Serge, Boyer, Louis, Abergel, Armand, Hillon, Patrick, Sautou, Valérie, Boulin, Mathieu

    المساهمون: CHU Clermont-Ferrand, Pharmacie CHU de Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Institut Pascal (IP), SIGMA Clermont (SIGMA Clermont)-Université Clermont Auvergne 2017-2020 (UCA 2017-2020 )-Centre National de la Recherche Scientifique (CNRS), Image Science for Interventional Techniques (ISIT), Université d'Auvergne - Clermont-Ferrand I (UdA)-Clermont Université-Centre National de la Recherche Scientifique (CNRS), Service de radiologie et d'Imagerie médicale diagnostique et thérapeutique (CHU de Dijon), Service d'épidémiologie et d'hygiène hospitalières (CHU de Dijon), Université Blaise Pascal - Clermont-Ferrand 2 (UBP)-SIGMA Clermont (SIGMA Clermont)-Centre National de la Recherche Scientifique (CNRS), Université Bourgogne Franche-Comté COMUE (UBFC)

    المصدر: ISSN: 0250-7005 ; Anticancer Research ; https://hal.science/hal-02095438Test ; Anticancer Research, 2014, 34 (12), pp.7247-53.

    مصطلحات موضوعية: Transarterial chemoembolization, efficacy, hepatocellular carcinoma, strategy, tolerance, MESH: Aged, MESH: Antibiotics, Antineoplastic, MESH: Female, MESH: Humans, MESH: Idarubicin, MESH: Infusions, Intra-Arterial, MESH: Liver Neoplasms, MESH: Male, MESH: Retrospective Studies, MESH: Treatment Outcome, MESH: Carcinoma, Hepatocellular, MESH: Chemoembolization, Therapeutic, MESH: Epirubicin, MESH: Ethiodized Oil, [SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing, [SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25503156; hal-02095438; https://hal.science/hal-02095438Test; PUBMED: 25503156

    الإتاحة: https://hal.science/hal-02095438Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Non-lethal Right Liver Atrophy After TIPS Occlusion in A Cirrhotic Patient: Introducing The Hepatic Biembolization ; Comparison of two transarterial chemoembolization strategies for hepatocellular carcinoma.

    المؤلفون: Le Roy, Bertrand, Gagniere, Johan, Pezet, Denis, Buc, Emmanuel, Tavernier, Jerome, Fagnoni, Philippe, Chabrot, Pascal, Guiu, Boris, Vadot, Lucie, Aho, Serge, Boyer, Louis, Abergel, Armand, Hillon, Patrick, Sautou, Valérie, Boulin, Mathieu

    المساهمون: CHU Estaing Clermont-Ferrand, CHU Clermont-Ferrand, Service Chirurgie Disgestive, CHU Clermont-Ferrand-CHU Clermont-Ferrand, Microbes, Intestin, Inflammation et Susceptibilité de l'Hôte (M2iSH), Institut National de la Recherche Agronomique (INRA)-Université d'Auvergne - Clermont-Ferrand I (UdA), Pharmacie CHU de Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Institut Pascal (IP), SIGMA Clermont (SIGMA Clermont)-Centre National de la Recherche Scientifique (CNRS)-Université Clermont Auvergne 2017-2020 (UCA 2017-2020 ), Service de radiologie et d'Imagerie médicale diagnostique et thérapeutique (CHU de Dijon), Service d'épidémiologie et d'hygiène hospitalières (CHU de Dijon), Image Science for Interventional Techniques (ISIT), Université d'Auvergne - Clermont-Ferrand I (UdA)-Clermont Université-Centre National de la Recherche Scientifique (CNRS), Université Bourgogne Franche-Comté COMUE (UBFC), Institut de Chimie de Clermont-Ferrand (ICCF), SIGMA Clermont (SIGMA Clermont)-Institut de Chimie du CNRS (INC)-Université Clermont Auvergne 2017-2020 (UCA 2017-2020 )-Centre National de la Recherche Scientifique (CNRS)

    المصدر: ISSN: 0250-7005 ; Anticancer Research ; https://hal.archives-ouvertes.fr/hal-02095434Test ; Anticancer Research, International Institute of Anticancer Research, 2014, 34 (12), pp.7247-53. ⟨10.1007/s11605-016-3133-z⟩.

    مصطلحات موضوعية: Transarterial chemoembolization, efficacy, hepatocellular carcinoma, strategy, tolerance, MESH: Aged, MESH: Antibiotics, Antineoplastic, MESH: Liver Neoplasms, MESH: Male, MESH: Retrospective Studies, MESH: Treatment Outcome, MESH: Carcinoma, Hepatocellular, MESH: Chemoembolization, Therapeutic, MESH: Epirubicin, MESH: Ethiodized Oil, MESH: Female, MESH: Humans, MESH: Idarubicin, MESH: Infusions, Intra-Arterial, [SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing, [SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25503156; hal-02095434; https://hal.archives-ouvertes.fr/hal-02095434Test; PUBMED: 25503156

    الإتاحة: https://doi.org/10.1007/s11605-016-3133-zTest
    https://hal.archives-ouvertes.fr/hal-02095434Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Comparison of two transarterial chemoembolization strategies for hepatocellular carcinoma.

    المؤلفون: Tavernier, Jerome, Fagnoni, Philippe, Chabrot, Pascal, Guiu, Boris, Vadot, Lucie, Aho, Serge, Boyer, Louis, Abergel, Armand, Hillon, Patrick, Sautou, Valérie, Boulin, Mathieu

    المساهمون: CHU Clermont-Ferrand, Pharmacie CHU de Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Institut Pascal (IP), SIGMA Clermont (SIGMA Clermont)-Centre National de la Recherche Scientifique (CNRS)-Université Clermont Auvergne 2017-2020 (UCA 2017-2020 ), Image Science for Interventional Techniques (ISIT), Université d'Auvergne - Clermont-Ferrand I (UdA)-Clermont Université-Centre National de la Recherche Scientifique (CNRS), Service de radiologie et d'Imagerie médicale diagnostique et thérapeutique (CHU de Dijon), Service d'épidémiologie et d'hygiène hospitalières (CHU de Dijon), Université Blaise Pascal - Clermont-Ferrand 2 (UBP)-SIGMA Clermont (SIGMA Clermont)-Centre National de la Recherche Scientifique (CNRS), Université Bourgogne Franche-Comté COMUE (UBFC)

    المصدر: ISSN: 0250-7005 ; Anticancer Research ; https://hal.archives-ouvertes.fr/hal-02095438Test ; Anticancer Research, International Institute of Anticancer Research, 2014, 34 (12), pp.7247-53.

    مصطلحات موضوعية: strategy, hepatocellular carcinoma, efficacy, Transarterial chemoembolization, tolerance, MESH: Aged, MESH: Antibiotics, Antineoplastic, MESH: Female, MESH: Humans, MESH: Idarubicin, MESH: Infusions, Intra-Arterial, MESH: Liver Neoplasms, MESH: Male, MESH: Retrospective Studies, MESH: Treatment Outcome, MESH: Carcinoma, Hepatocellular, MESH: Chemoembolization, Therapeutic, MESH: Epirubicin, MESH: Ethiodized Oil, [SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing, [SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25503156; hal-02095438; https://hal.archives-ouvertes.fr/hal-02095438Test; PUBMED: 25503156

    الإتاحة: https://hal.archives-ouvertes.fr/hal-02095438Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث